Ryan Fischer

Ryan Fischer is the Chief Operating Officer for the Foundation for Angelman Syndrome Therapeutics or FAST. Ryan works with FAST’s President to establish, direct, and achieve the organization’s short and long-term strategic goals and objectives across all operational areas, including general administration, programs, grants, and stakeholder relations. He is also tasked with maintaining and building effective relationships with key stakeholders, including Congress, regulators, pharmaceutical companies, other foundation leaders, and the broader rare disease advocacy community. Before joining FAST, Ryan served as Chief Advocacy Officer for Parent Project Muscular Dystrophy (PPMD). Ryan held various roles within PPMD over 18 years, helping to grow the organization into one of the leading rare diseases advocacy nonprofits globally.